SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors
- 5 December 2005
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (5), 1320-1323
- https://doi.org/10.1016/j.bmcl.2005.11.053
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mechanism of Aurora B Activation by INCENP and Inhibition by HesperadinMolecular Cell, 2005
- Progress in the development of selective inhibitors of Aurora kinases.Current Topics in Medicinal Chemistry, 2005
- Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinibBritish Journal of Cancer, 2004
- VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivoNature Medicine, 2004
- Structural Basis of Aurora-A Activation by TPX2 at the Mitotic SpindleMolecular Cell, 2003
- Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochoresThe Journal of cell biology, 2003
- Structures of the Cancer-Related Aurora-A, FAK, and EphA2 Protein Kinases from Nanovolume CrystallographyStructure, 2002
- Crystal Structure of Aurora-2, an Oncogenic Serine/Threonine KinasePublished by Elsevier BV ,2002
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancersThe EMBO Journal, 1998